Bicocca Open Archive

Logo unimib boa
SMITH, ANDREW
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.606
EU - Europa 4.897
AS - Asia 2.456
SA - Sud America 116
AF - Africa 19
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.482
IT - Italia 1.657
SG - Singapore 948
DE - Germania 742
CN - Cina 738
IE - Irlanda 631
SE - Svezia 504
HK - Hong Kong 355
RU - Federazione Russa 340
AT - Austria 221
GB - Regno Unito 212
UA - Ucraina 150
VN - Vietnam 134
CA - Canada 107
BR - Brasile 94
FR - Francia 90
DK - Danimarca 80
IN - India 67
FI - Finlandia 61
ID - Indonesia 59
NL - Olanda 58
TR - Turchia 41
BE - Belgio 27
JP - Giappone 25
CH - Svizzera 16
ES - Italia 14
KR - Corea 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
PL - Polonia 13
MX - Messico 12
IR - Iran 11
GR - Grecia 10
NO - Norvegia 9
RO - Romania 9
AU - Australia 8
IL - Israele 8
HR - Croazia 7
TH - Thailandia 7
EC - Ecuador 6
EG - Egitto 6
PH - Filippine 6
PT - Portogallo 6
LT - Lituania 5
LV - Lettonia 5
MY - Malesia 5
AR - Argentina 4
BG - Bulgaria 4
HU - Ungheria 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BO - Bolivia 3
DZ - Algeria 3
PK - Pakistan 3
UZ - Uzbekistan 3
CR - Costa Rica 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PS - Palestinian Territory 2
SC - Seychelles 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
ML - Mali 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 15.105
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.696
Singapore 644
Dublin 617
Milan 600
Fairfield 582
Chandler 581
Frankfurt am Main 528
Wilmington 455
Ashburn 426
Woodbridge 365
Hong Kong 343
Houston 313
Dearborn 301
Santa Clara 261
New York 253
Seattle 248
Vienna 199
Princeton 188
Cambridge 184
Jacksonville 145
Shanghai 137
Nanjing 128
Dong Ket 111
Jakarta 54
Lawrence 49
Rome 46
Beijing 45
Nanchang 45
Altamura 41
Council Bluffs 39
Guangzhou 39
Los Angeles 38
Falls Church 37
Lissone 37
Shenyang 37
Helsinki 35
London 35
San Diego 34
Fremont 32
Hebei 29
Andover 28
Toronto 27
Ottawa 26
Nuremberg 24
Changsha 23
Pune 23
Brussels 22
Florence 22
Chicago 21
Jiaxing 21
Boardman 18
Cinisello Balsamo 18
Jinan 18
Lachine 18
Monza 18
Pavia 17
Zhengzhou 17
Absecon 16
Caronno Pertusella 16
Norwalk 16
Brescia 15
Hangzhou 15
Ningbo 15
Tianjin 15
Madison 14
Montréal 14
Terni 14
Kunming 13
Padova 13
San Giuliano Milanese 13
Munich 12
Sesto San Giovanni 12
Turin 12
Cagliari 11
Centro Municipality 11
Edmonton 11
Lille 11
Bonndorf 10
Carate Brianza 10
Hefei 10
Kiev 10
Leiden 10
Washington 10
Fermignano 9
Melzo 9
Mountain View 9
Rho 9
Romola 9
Sacramento 9
Verona 9
Dallas 8
Naples 8
Napoli 8
Ripalta Cremasca 8
San Mateo 8
São Paulo 8
Tokyo 8
Birmingham 7
Brno 7
Daejeon 7
Totale 10.807
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 437
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 379
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 311
MALDI imaging in Fabry nephropathy: a multicenter study 306
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 286
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 275
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 275
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 274
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 273
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 272
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 264
The proteomic landscape of renal tumors 258
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 258
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 246
The putative role of MALDI-MSI in the study of Membranous Nephropathy 243
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 243
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 242
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 242
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 239
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 234
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 234
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 224
Proteomics for the diagnosis of thyroid lesions: Preliminary report 222
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 221
Proteomics for the study of new biomarkers in Fabry disease: State of the art 211
Tumor size, stage and grade alterations of urinary peptidome in RCC 208
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 207
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 203
Proteome analysis in thyroid pathology 202
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 202
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 188
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 179
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 178
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 176
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 171
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 169
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 169
A molecular imaging approach to individuate tumour infiltrating lymphocytes 167
Intraluminal proteome and peptidome of human urinary extracellular vesicles 166
The role of fine needle aspiration of orbital lesions: A case series 165
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 162
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 161
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 159
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 158
Machine learning approaches in MALDI-MSI: clinical applications 153
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 150
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 149
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 147
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 142
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 140
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 139
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 134
MALDI-MS imaging in the study of glomerulonephritis 131
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 125
The putative role of MALDI-MSI in the study of Membranous Nephropathy 119
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 116
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 113
The putative role of MALDI-MSI in the study of Membranous Nephropathy 111
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 105
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 104
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 104
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 102
α-1-antitrypsin detected by MALDI-Imaging in the study of glomerulonephritis: its relevance in chronic kidney disease progression 102
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 101
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 98
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 98
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 97
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 94
The Reed-Stanton press rig for the generation of reproducible fingermarks: Towards a standardised methodology for fingermark research 93
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 92
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 91
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 90
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 90
Determining the Age of a Latent Fingermark: Applying a Novel MALDI-MSI Methodology to an Age Old Forensic Conundrum 87
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 86
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 83
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 82
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 81
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 80
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 80
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 79
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 79
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 79
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 78
Precision medicine for Diabetic Nephropathy and Hypertensive Nephrosclerosis 76
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 76
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 75
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 73
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 73
Sample preparation considerations in MALDI-MS Imaging: What is your goal? 70
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients 68
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 67
MALDI mass spectrometry imaging in the analysis of primary glomerulonephritis 66
Correlazione di dati ottenuti con l’immagine istologica e microdissezione virtuale 66
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 65
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 65
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 64
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 59
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 59
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 54
Totale 15.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020375 0 0 0 0 0 0 0 0 0 149 169 57
2020/20212.332 98 111 244 290 219 233 191 256 154 169 124 243
2021/20221.490 119 143 91 162 114 145 39 83 60 113 149 272
2022/20232.574 298 692 241 199 101 393 47 200 171 37 113 82
2023/20242.134 75 84 82 145 196 584 436 52 132 36 82 230
2024/20252.959 224 449 344 213 437 183 310 196 595 8 0 0
Totale 15.996